Jeremy Whalen, PharmD, BCOP
Advertisement
Articles by Jeremy Whalen, PharmD, BCOP
Advertisement
Latest Updated Articles
- Recognizing and Addressing Challenges to the Adoption of Trastuzumab Biosimilars and HER2-Targeted Therapies
Published: April 9th 2020 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Sibeprenlimab for Immunoglobulin A Nephropathy
2
Patients Face New Care Complexities as DTC Options Expand
3
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
4
Expiring ACA Subsidies and CMS Payment Models Raise Costs for Consumers and Employers
5
